Edwards Lifesciences Corporation (EW)
NYSE·Healthcare·Medical - Devices
$81.85
-1.93%
Mkt Cap $47.30B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q2 2026 Apr 23, 2026 | $1.60B | $1.65B | +3.24% | $0.73 | $0.78 | +7.00% | — | — |
| Q1 2026 Feb 10, 2026 | $1.55B | $1.57B | +1.47% | $0.62 | $0.58 | -6.15% | — | — |
| Q4 2025 Oct 30, 2025 | $1.50B | $1.55B | +3.69% | $0.60 | $0.67 | +12.42% | — | — |
| Q3 2025 Jul 24, 2025 | $1.49B | $1.53B | +2.97% | $0.62 | $0.67 | +7.37% | — | — |
| Q2 2025 Apr 23, 2025 | $1.40B | $1.41B | +0.87% | $0.60 | $0.64 | +7.38% | — | — |
| Q1 2025 Feb 11, 2025 | $1.36B | $1.39B | +1.98% | $0.55 | $0.59 | +7.08% | — | — |
| Q4 2024 Oct 24, 2024 | $1.54B | $1.35B | -12.31% | $0.67 | $0.67 | +0.75% | — | — |
| Q3 2024 Jul 24, 2024 | $1.65B | $1.39B | -16.17% | $0.69 | $0.70 | +1.45% | — | — |
| Q2 2024 Apr 25, 2024 | $1.57B | $1.60B | +1.80% | $0.64 | $0.66 | +3.13% | — | — |
| Q1 2024 Feb 6, 2024 | $1.49B | $1.53B | +2.69% | $0.64 | $0.64 | +0.00% | — | — |
| Q4 2023 Oct 25, 2023 | $1.48B | $1.48B | +0.14% | $0.59 | $0.59 | +0.00% | — | — |
| Q3 2023 Jul 26, 2023 | $1.50B | $1.53B | +1.81% | $0.65 | $0.66 | +1.54% | — | — |
| Q2 2023 Apr 26, 2023 | $1.39B | $1.46B | +4.79% | $0.61 | $0.62 | +1.64% | — | — |
| Q1 2023 Jan 31, 2023 | $1.33B | $1.35B | +1.09% | $0.61 | $0.64 | +4.92% | — | — |
| Q4 2022 Oct 27, 2022 | $1.33B | $1.32B | -1.12% | $0.62 | $0.61 | -1.61% | — | — |
| Q3 2022 Jul 28, 2022 | $1.40B | $1.37B | -1.60% | $0.64 | $0.63 | -1.56% | — | — |
| Q2 2022 Apr 26, 2022 | $1.31B | $1.34B | +2.37% | $0.57 | $0.60 | +5.26% | — | — |
| Q1 2022 Jan 26, 2022 | $1.35B | $1.33B | -1.72% | $0.55 | $0.51 | -7.27% | — | — |
| Q4 2021 Oct 27, 2021 | $1.33B | $1.31B | -1.54% | $0.53 | $0.54 | +1.89% | — | — |
| Q3 2021 Jul 29, 2021 | $1.38B | $1.38B | +0.00% | $0.56 | $0.64 | +14.29% | — | — |